At our institution, injectable nitroglycerin (TNG) has been employed dur ing cardiac catheterization since 1976. Initially, it was primarily used in pa tients undergoing a provocative test for coronary spasm with ergonovine maleate. After the initial favorable experience, the use of injectable TNG became routine. 1,2
Get full access to this article
View all access options for this article.
References
1.
Gensini GG: Coronary arteriography. In: Heart Disease, ed. by Braunwald E. Philadelphia, Saunders, 1980, p. 340.
2.
Gensini GG, Esente P., Giambartolomei A., et al: Use of intracardiac nitroglycerin during cardiac catheterization . Cardiovasc Inter-vent Radiol4:270, 1981.
3.
Come PC, and Pitt B.: Nitroglycerin-induced severe hypotension and bradycardia in patients with acute myocardial infarction. Circ54:624, 1976.
4.
Buxton A., Goldberg S., Hirshfeld J., et al: Refractory ergonovine induced coronary vasospasm, importance of intracoronary nitroglycerin. Am J Cardiol46:326, 1980.
5.
Heupler FA, Jr.: Provocative test for coronary artery spasm: risk, method and rationale. Am J Cardiol46:335, 1980.
6.
Chetterjee K. , Parmley WW, Swan Hjc, et al: Beneficial effects of vasodilator agents in severe mitral regurgitation due to dysfunction of subvalvular apparatus . Circ48:684, 1973.
